News | October 11, 2021
Merck and Ridgeback seek EUA from U.S. FDA for molnupiravir
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis (EoE)
Quantitative restrictions in place to meet domestic needs to cater to the vaccination programme
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
The company plans to expand its portfolio in regulated markets aggressively
This opens up a huge market for the company’s Magnezis implants in India
The platform will provide a safe and nurturing space for women, and non-binary individuals
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
Subscribe To Our Newsletter & Stay Updated
